
The Neuberger High Yield Strategies Fund Inc., identified by its symbol NHS, is a closed-end investment vehicle focused on fixed income. Established by Neuberger Berman LLC and overseen by Neuberger Berman Investment Advisers LLC, it allocates capital to debt instruments in global markets. The fund primarily targets high-yield bonds issued by companies across numerous sectors, such as automotive components and equipment, airlines, the broader automotive industry, electronics, healthcare services, packaging, integrated and service-based telecommunications, gaming, and natural gas distribution…
Is NHS's expense ratio expensive, average, or a steal for its category?
Pro reveals the verdict on a 5-tier spectrum calibrated against ICI 2025 industry averages, with strategy-aware bands so the comparison is meaningful.

The expansion, launched in partnership with Apian, will help provide faster pediatric care for one of the world's leading children's hospitals The expansion, launched in partnership with Apian, will help provide faster pediatric care for one of the world's leading children's hospitals

NEW YORK, Sept. 30, 2026 /PRNewswire/ -- Neuberger High Yield Strategies Fund Inc. (NYSE American: NHS) (the "Fund") has announced a distribution declaration of $0.0905 per share of common stock.

Ondine Biomedical Inc (AIM:OBI, OTC:OBIMF) has won support from Peel Hunt after partnering with Mela Solutions to accelerate access for its Steriwave infection-prevention technology across NHS intensive care units. Peel Hunt retained its ‘buy' rating and 29p price target, highlighting the potential for the collaboration to generate trust-specific evidence on Steriwave's clinical and economic benefits.

Ondine Biomedical Inc (AIM:OBI, OTC:OBIMF) has teamed up with Mela Solutions, whose software sits in 90% of NHS intensive care units, to help hospitals test whether its Steriwave system saves them money. Steriwave uses light to activate an antimicrobial treatment applied inside the nose, killing bacteria that can cause infections in hospital patients.

The Neuberger High Yield Strategies Fund offers a 19.15% yield but struggles to cover its distribution, risking net asset value destruction. NHS is almost entirely allocated to fixed-rate high-yield bonds, making it vulnerable in a rising rate and inflationary environment. Despite trading at an 11.13% discount to NAV, NHS has underperformed junk bond indices and is not earning enough to justify its payout.